ICU MEDICAL INC (ICUI) Stock Price, Quote, News and Overview
NASDAQ:ICUI - Nasdaq - US44930G1076 - Common Stock - Currency: USD
ICUI Quote, Performance and Key Statistics
157.47
-5.68 (-3.48%)
The current stock price of ICUI is 157.47 USD. In the past month the price decreased by -2.31%. In the past year, price increased by 57.5%.
ICUI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ALC | ALCON INC | 29.9 | 45.13B | ||
| COO | COOPER COS INC/THE | 23.92 | 17.66B | ||
| ALGN | ALIGN TECHNOLOGY INC | 20.4 | 14.22B | ||
| SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 30.69 | 6.01B | ||
| BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
| XRAY | DENTSPLY SIRONA INC | 10.13 | 3.73B | ||
| HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
| NEOG | NEOGEN CORP | 25.13 | 2.18B | ||
| UFPT | UFP TECHNOLOGIES INC | 36.38 | 1.96B | ||
| RXST | RXSIGHT INC | N/A | 1.19B |
Related stock screener links
About ICUI
Company Profile
ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 14,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needle free IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy product include Portex BLUselect PVC tracheostomy tubes.
Company Info
ICU MEDICAL INC
951 Calle Amanecer
San Clemente CALIFORNIA 92763 US
CEO: Vivek Jain
Employees: 14000
Company Website: https://www.icumed.com/
Investor Relations: http://ir.icumed.com
Phone: 19493662183
ICU MEDICAL INC / ICUI FAQ
What is the stock price of ICU MEDICAL INC today?
The current stock price of ICUI is 157.47 USD. The price decreased by -3.48% in the last trading session.
What is the ticker symbol for ICU MEDICAL INC stock?
The exchange symbol of ICU MEDICAL INC is ICUI and it is listed on the Nasdaq exchange.
On which exchange is ICUI stock listed?
ICUI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ICU MEDICAL INC stock?
11 analysts have analysed ICUI and the average price target is 213.95 USD. This implies a price increase of 35.86% is expected in the next year compared to the current price of 157.47. Check the ICU MEDICAL INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ICU MEDICAL INC worth?
ICU MEDICAL INC (ICUI) has a market capitalization of 3.85B USD. This makes ICUI a Mid Cap stock.
How many employees does ICU MEDICAL INC have?
ICU MEDICAL INC (ICUI) currently has 14000 employees.
What are the support and resistance levels for ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a support level at 163.01 and a resistance level at 169.2. Check the full technical report for a detailed analysis of ICUI support and resistance levels.
Is ICU MEDICAL INC (ICUI) expected to grow?
The Revenue of ICU MEDICAL INC (ICUI) is expected to grow by 4.47% in the next year. Check the estimates tab for more information on the ICUI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ICU MEDICAL INC (ICUI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ICUI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ICUI, evaluating the profitability, health, valuation and growth aspects
- ICU MEDICAL INC (ICUI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ICU MEDICAL INC (ICUI) Sales and EPS estimates to see what analysts future expectations are.
- ICU MEDICAL INC (ICUI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ICU MEDICAL INC (ICUI) Insider and Institutional Ownership to learn about the owners and their transactions.
- ICU MEDICAL INC (ICUI) Stock Chart to make your own analysis
- ICU MEDICAL INC (ICUI) Latest news and press-releases to stay up to date.
Does ICU MEDICAL INC (ICUI) stock pay dividends?
ICUI does not pay a dividend.
When does ICU MEDICAL INC (ICUI) report earnings?
ICU MEDICAL INC (ICUI) will report earnings on 2025-03-04, after the market close.
What is the Price/Earnings (PE) ratio of ICU MEDICAL INC (ICUI)?
The PE ratio for ICU MEDICAL INC (ICUI) is 27.72. This is based on the reported non-GAAP earnings per share of 5.68 and the current share price of 157.47 USD. Check the full fundamental report for a full analysis of the valuation metrics for ICUI.
What is the Short Interest ratio of ICU MEDICAL INC (ICUI) stock?
The outstanding short interest for ICU MEDICAL INC (ICUI) is 3.23% of its float. Check the ownership tab for more information on the ICUI short interest.
ICUI Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to ICUI. When comparing the yearly performance of all stocks, ICUI is one of the better performing stocks in the market, outperforming 87.94% of all stocks.
ICUI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ICUI. While ICUI seems to be doing ok healthwise, there are quite some concerns on its profitability.
ICUI Financial Highlights
Over the last trailing twelve months ICUI reported a non-GAAP Earnings per Share(EPS) of 5.68. The EPS decreased by -16.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.58% | ||
| ROE | -5.42% | ||
| Debt/Equity | 0.75 |
ICUI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 82% to ICUI. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of -15.48% and a revenue growth 4.47% for ICUI